SEARCH

SEARCH BY CITATION

References

  • Acevedo L. D., Holloway H. W., Rapoport S. I. and Shetty H. U. (1997) Application of stable isotope tracer combined with mass spectrometric detection for studying myo-inositol uptake by cultured neurons from fetal mouse: effect of trisomy 16. J. Mass Spectrom. 32, 395400.DOI: 10.1002/(SICI)1096-9888(199704)32:4<395::AID-JMS487>3.0.CO;2-#
  • Agranoff B. W. and Fisher S. K. (2001) Inositol, lithium and the brain. Psychopharmacol. Bull. 35, 518.
  • Albert C., Safrany S. T., Bembenek M. E., Reddy K. M., Reddy K., Falck J., Brocker M., Shears S. B. and Mayr G. W. (1997) Biological variability in the structures of diphosphoinositol polyphosphates in Dictyostelium discoideum and mammalian cells. Biochem. J. 327, 553560.
  • Ali N., Duden R., Bembenek M. E. and Shears S. B. (1995) The interaction of coatomer with inositol polyphosphates is conserved in Saccharomyces cerevisiae. Biochem. J. 310, 279284.
  • Allison J. H. and Stewart M. A. (1971) Reduced brain inositol in lithium-treated rats. Nat. New Biol. 233, 267268.
  • Allison J. H., Blisner M. E., Holland W. H., Hipps P. P. and Sherman W.R. (1976) Increased brain myo-inositol 1-phosphate in lithium-treated rats. Biochem. Biophys. Res. Commun. 71, 664670.
  • Arner R. J., Prabhu K. S., Thompson J. T., Hildenbrandt G. R., Liken A.D. and Reddy C. C. (2001) myo-Inositol oxygenase. molecular cloning and expression of a unique enzyme that oxidizes myo-inositol and d-chiro-inositol. Biochem. J. 360, 313320.
  • Barak Y., Levine J., Glasman A., Elizur A. and Belmaker R. H. (1996) Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial. Prog. Neuropsychopharmaco. Biol. Psychiatry 20, 729735.
  • Barkai A. I., Dunner D. L., Gross H. A., Mayo P. and Fieve R. R. (1978) Reduced myo-inositol levels in cerebrospinal fluid from patients with affective disorder. Biol. Psychiatry 13, 6572.
  • Battaglia F. C., Meschia G., Blechner J. N. and Barron D. H. (1961) The free myo-inositol concentration of adult and fetal tissues of several species. Quart. J. Exp. Physiol. 46, 188193.
  • Batty I. and Nahorski S. R. (1985) Differential effects of lithium on muscarinic receptor stimulation of inositol phosphates in rat cerebral cortex slices. J. Neurochem. 45, 15141521.
  • Batty I. H., Michie A., Fennel M. and Downes C. P. (1993) The characteristics, capacity and receptor regulation of inositol uptake in 1321N1 astrocytoma cells. Biochem. J. 294, 4955.
  • Belmaker R. H., Agam G., Van Calker D., Richards M. H. and Kofman O. (1998) Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus, and inositol levels may be abnormal in postmortem brain from bipolar patients. Neuropsychopharmacology 19, 220232.
  • Benjamin J., Levine J., Fux M., Aviv A., Levy D. and Belmaker R. H. (1995) Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am. J. Psychiatry 152, 10841086.
  • Benjamins J. A. and Agranoff B. W. (1969) Distribution and properties of CDP-diglyceride: inositol transferase from brain. J. Neurochem. 16, 513527.
  • Berridge M. J. (1987) Inositol trisphosphate and diacylglycerol: two interacting second messengers. Ann. Rev. Biochem. 56, 159193.
  • Berridge M. J., Downes C. P. and Hanley M. R. (1982) Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem. J. 206, 587595.
  • Berridge M. J., Downes C. P. and Hanley M. R. (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59, 411419.
  • Berry G. T., Mallee J. J., Kwon H. M., Rim J. S., Mulla W. R., Muenke M. and Spinner N. B. (1995) The human osmoregulatory Na+/myo-inositol cotransporter gene (SLC5A3): molecular cloning and localization to chromosome 21. Genomics 25, 507513.
  • Berry G. T., Wang Z. J., Dreha S. F., Finucane B. M. and Zimmerman R.A. (1999) In vivo brain myo-inositol levels in children with Down syndrome. J. Pediatr. 135, 9497.
  • Bitoun M. and Tappaz M. (2000) Gene expression of taurine transporter and taurine biosynthetic enzymes in brain of rats with acute or chronic hyperosmotic plasma. A comparative study with gene expression of myo-inositol transporter, betaine transporter and sorbitol biosynthetic enzyme. Mol. Brain Res. 77, 1018.
  • Bouveault L. (1894) De l'isomérie optique dans les corps à chaines fermées. Bull. la Société Chimique Paris 11, 44147.
  • Brand A., Richter-Landsberg C. and Leibfritz D. (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev. Neurosci. 15, 289298.
  • Busa W. B. and Gimlich R. L. (1989) Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog. Dev. Biol. 132, 315324.
  • Caffrey J. J., Safrany S. T., Yang X. and Shears S. B. (2000) Discovery of molecular and catalytic diversity among human diphosphoinositol-polyphosphate phosphohydrolases. An expanding Nudt family. J. Biol. Chem. 275, 1273012736.
  • Charalampous F. C. (1958) Biochemical studies on inositol. V. Purification and properties of the enzyme that cleaves inositol to d-glucuronic acid. J. Biol. Chem. 234, 220227.
  • Clements R. S. Jr and Diethelm A. G. (1979) The metabolism of myo-inositol by the human kidney. J. Laboratory Clin. Med. 93, 210219.
  • Coady M. J., Pajor A. M. and Wright E. M. (1990) Sequence homologies among intestinal and renal Na+/glucose cotransporters. Am. J. Physiol. 259, C605C610.
  • Cosgrove D. J. (1980) Inositol Phosphates p. 15. Elsevier, Amsterdam.
  • Craxton A., Caffrey J. J., Burkhart W., Safrany S. T. and Shears S. B. (1997) Molecular cloning and expression of a rat hepatic multiple inositol polyphosphate phosphatase. Biochem. J. 328, 7581.
  • Culbertson M. R., Donahue T. F. and Henry S. A. (1976) Control of inositol biosynthesis in Saccharomyces cerevisiae: properties of a repressible enzyme system in extracts of wild-type (Ino+) cells. J.Bacteriol. 126, 232242.
  • Eagle H., Agranoff B. W. and Snell S. E. (1960) The biosynthesis of meso-inositol by cultured mammalian cells, and the parabiotic growth of inositol-dependent and inositol-independent strains. J.Biol. Chem. 235, 18911893.
  • Eastcott V. (1928) Wildiers' bios: the isolation and identification of ‘bios I.’. J. Phys. Chem. 32, 10941111.
  • Eichberg J. and Dawson R. M. (1965) Polyphosphoinositides in myelin. Biochem. J. 96, 644650.
  • Eisenberg F. Jr (1967) d-myoinositol 1-phosphate as product of cyclization of glucose 6-phosphate and substrate for a specific phosphatase in rat testis. J. Biol. Chem. 242, 13751382.
  • Europe-Finner G. N., Gammon B. and Newell P. C. (1991) Accumulation of [3H]-inositol into inositol polyphosphates during development of Dictyostelium. Biochem. Biophys. Res. Commun. 181, 191196.
  • Feng Y., Wente S. R. and Majerus P. W. (2001) Overexpression of the inositol phosphatase SopB in human 293 cells stimulates cellular chloride influx and inhibits nuclear mRNA export. Proc. Natl Acad. Sci. USA 98, 875879.
  • Fisher S. K. and Agranoff B. W. (1987) Receptor activation and inositol lipid hydrolysis in neural tissues. J. Neurochem. 48, 9991017.
  • Fisher S. K., Heacock A. M. and Agranoff B. W. (1992) Inositol lipids and signal transduction in the nervous system: an update. J. Neurochem. 58, 1838.
  • Fleischer B., Xie J., Mayrleitner M., Shears S. B., Palmer D. J. and Fleischer S. (1994) Golgi coatomer binds, and forms K+-selective channels gated by inositol polyphosphates. J. Biol. Chem. 269, 1782617832.
  • Folch J. and Woolley D. W. (1942) Inositol, a constituent of a brain phosphatide. J. Biol. Chem. 142, 963964.
  • Fruen B. R. and Lester B. R. (1991) High-affinity [3H]inositol uptake by dissociated brain cells and cultured fibroblasts from fetal mice. Neurochem. Res. 16, 913918.
  • Fukuda M., Aruga J., Niinobe M., Aimoto S. and Mikoshiba K. (1994) Inositol-1,3,4,5-tetrakisphosphate binding to C2B domain of IP4 BP/synaptotagmin II. J. Biol. Chem. 269, 2920629211.
  • Fux M., Levine J., Aviv A. and Belmaker R. H. (1996) Inositol treatment of obsessive compulsive disorder. Am. J. Psychiatry 153, 12191221.
  • Gaidarov I., Chen Q., Falck J. R., Reddy K. K. and Keen J. H. (1996) A functional phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain in the clathrin adaptor AP-2 α subunit. Implications for the endocytic pathway. J. Biol. Chem. 271, 2092220929.
  • Gaidarov I., Krupnick J. G., Falck J. R., Benovic J. L. and Keen J. H. (1999) Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding. EMBO J. 18, 871881.
  • Ghalayini A. and Eichberg J. (1985) Purification of phosphatidylinositol synthetase from rat brain by CDP-diacylglycerol affinity chromatography and properties of the purified enzyme. J. Neurochem. 44, 175182.
  • Gillon K. R. and Hawthorne J. N. (1983) Transport of myo-inositol into endoneurial preparations of sciatic nerve from normal and streptozotocin-diabetic rats. Biochem. J. 210, 775781.
  • Glanville N. T., Byers D. M., Cook H. W., Spence M. W. and Palmer F. B. (1989) Differences in the metabolism of inositol and phosphoinositides by cultured cells of neuronal and glial origin. Biochim. Biophys. Acta. 1004, 169179.
  • Glennon M. C. and Shears S. B. (1993) Turnover of inositol pentakisphosphates, inositol hexakisphosphate and diphosphoinositol polyphosphates in primary cultured hepatocytes. Biochem. J. 293, 583590.
  • Godfrey P. P. (1989) Potentiation by lithium of CMP-phosphatidate formation in carbachol-stimulated rat cerebral-cortical slices and its reversal by myo-inositol. Biochem. J. 258, 621624.
  • Godfrey D. A., Hallcher L. M., Laird M. H., Matschinsky F. M. and Sherman W. R. (1982) Distribution of myo-inositol in the cat cochlear nucleus. J. Neurochem. 38, 939947.
  • Goldstein L. and Davis E. (1994) Taurine, betaine, and inositol share a volume-sensitive transporter in skate erythrocyte cell membrane. Am. J. Physiol. 267, R426R431.
  • González E., Sánchez-Olea R. and Pasantes-Morales H. (1995) Inhibition by Cl channel blockers of the volume-activated, diffusional mechanism of inositol transport in primary astrocytes in culture. Neurochem. Res. 20, 895900.
  • Graf E., Empson K. L. and Eaton J. W. (1987) Phytic acid. A natural antioxidant. J. Biol. Chem. 262, 1164711650.
  • Grases F., García-Gonzalez R., Torres J. J. and Llobera A. (1998) Effects of phytic acid on renal stone formation in rats. Scand. J. Urol. Nephrol. 32, 262265.
  • Gray D. W., Challiss R. A. and Nahorski S. R. (1994) Differential effects of lithium on muscarinic cholinoceptor-stimulated CMP-phosphatidate accumulation in cerebellar granule cells, CHO-M3 cells, and SH-SY5Y neuroblastoma cells. J. Neurochem. 63, 13541360.
  • Greene N. D. and Copp A. J. (1997) Inositol prevents folate-resistant neural tube defects in the mouse. Nat. Med. 3, 6066.
  • Greene D. A. and Lattimer S. A. (1982) Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. J. Clin. Invest. 70, 10091018.
  • Gullans S. R. and Verbalis J. G. (1993) Control of brain volume during hyperosmolar and hypoosmolar conditions. Annu. Rev. Med. 44, 289301.
  • Guo W., Shimada S., Tajiri H., Yamauchi A., Yamashita T., Okada S. and Tohyama M. (1997) Developmental regulation of Na+/myo-inositol cotransporter gene expression. Brain Res. Mol. Brain Res. 51, 9196.
  • Hager K., Hazama A., Kwon H. M., Loo D. D., Handler J. S. and Wright E. M. (1995) Kinetics and specificity of the renal Na+/myo-inositol cotransporter expressed in Xenopus oocytes. J. Membr. Biol. 143, 103113.
  • Hallcher M. and Sherman W. R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255, 1089610901.
  • Hanakahi L. A., Bartlet-Jones M., Chappell C., Pappin D. and West S. C. (2000) Binding of inositol phosphate to DNA-PK and stimulation of double-strand break repair. Cell 102, 721729.
  • Hauser G. and Finelli V. N. (1963) The biosynthesis of free and phosphatide myo-inositol from glucose in mammalian tissues. J. Biol. Chem. 238, 32243228.
  • Haussinger D.,Laubenberger J.,Vom Dahl S.,Ernst T.,Bayer S.,Langer M.,Gerok W. and Hennig J. (1994) Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 107, 14751480.
  • Heacock A. M., Seguin E. B. and Agranoff B. W. (1993) Measurement of receptor-activated phosphoinositide turnover in rat brain: nonequivalence of inositol phosphate and CDP-diacylglycerol formation. J. Neurochem. 60, 10871092.
  • Hediger M. A., Coady M. J., Ikeda T. S. and Wright E. M. (1987) Expression cloning and cDNA sequencing of the Na+/glucose co-transporter. Nature 330, 379381.
  • Hilton J. M., Plomann M., Ritter B., Modregger J., Freeman H. N., Falck J. R., Krishna U. M. and Tobin A. B. (2001) Phosphorylation of a synaptic vesicle-associated protein by an inositol hexakisphosphate-regulated protein kinase. J. Biol. Chem. 276, 1634116347.
  • Höer A., Höer D. and Oberdisse E. (1990) Properties of a soluble inositol 1,3,4,5-tetrakisphosphate 3-phosphatase from porcine brain. Biochem. J. 270, 715719.
  • Hokin M. R. and Hokin L. E. (1953) Enzyme secretion and the incorporation of P32 into phospholipides of pancreas slices. J. Biol. Chem. 203, 967977.
  • Hokin L. and Hokin M. R. (1955) Effects of acetylcholine on the turnover of phosphoryl units in individual phospholipids of pancreas slices and brain cortex slices. Biochim. Biophys. Acta 18, 102110.
  • Holub B. J. (1986) Metabolism and function of myo-inositol and inositol phospholipids. Annu. Rev. Nutr. 6, 563597.
  • Hua L. V., Green M., Warsh J. J. and Li P. P. (2001) Molecular cloning of a novel isoform of diphosphoinositol polyphosphate phosphohydrolase: a potential target of lithium therapy. Neuropsychopharmacology 24, 640651.
  • Huang C. F., Voglmaier S. M., Bembenek M. E., Saiardi A. and Snyder S. H. (1998) Identification and purification of diphosphoinositol pentakisphosphate kinase, which synthesizes the inositol pyrophosphate bis (diphospho) inositol tetrakisphosphate. Biochemistry 37, 1499815004.
  • Huang W., Alexander G. E., Daly E. M., Shetty H. U., Krasuski J. S., Rapoport S. I. and Schapiro M. B. (1999) High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. Am. J. Psychiatry 156, 18791886.
  • Ibsen L. and Strange K. (1996) In situ localization and osmotic regulation of the Na+-myo-inositol cotransporter in rat brain. Am. J. Physiol. 271, F877F885.
  • Imai A. and Gershengorn M. C. (1987) Independent phosphatidylinositol synthesis in pituitary plasma membrane and endoplasmic reticulum. Nature 325, 726728.
  • Inoue K., Shimada S., Minami Y., Morimura H., Miyai A., Yamauchi A. and Tohyama M. (1996) Cellular localization of Na+/MYO-inositol co-transporter mRNA in the rat brain. Neuroreport 7, 11951198.
  • Irvine R. F. and Schell M. J. (2001) Back in the water: the return of the inositol phosphates. Nat. Rev. Mol. Cell Biol. 2, 327338.DOI: 10.1038/35073015
  • Isaacks R. E., Bender A. S., Kim C. Y. and Norenberg M. D. (1997) Effect of osmolality and myo-inositol deprivation on the transport properties of myo-inositol in primary astrocyte cultures. Neurochem. Res. 22, 14611469.
  • Isaacks R. E., Bender A. S., Kim C. Y., Prieto N. M. and Norenberg M.D. (1994) Osmotic regulation of myo-inositol uptake in primary astrocyte cultures. Neurochem. Res. 19, 331338.
  • Isaacks R. E., Bender A. S., Kim C. Y., Shi Y. F. and Norenberg M. D. (1999a) Effect of osmolality and anion channel inhibitors on myo-inositol efflux in cultured astrocytes. J. Neurosci. Res. 57, 866871.
  • Isaacks R. E., Bender A. S., Kim C. Y., Shi Y. F. and Norenberg M. D. (1999b) Effect of ammonia and methionine sulfoximine on myo-inositol transport in cultured astrocytes. Neurochem. Res. 24, 5159.
  • Isaacks R. E., Bender A. S., Reuben J. S., Kim C. Y., Shi Y. F. and Norenberg M. D. (1999c) Effect of dibutyryl cyclic AMP on the kinetics of myo-inositol transport in cultured astrocytes. J. Neurochem. 73, 105111.
  • IUPAC-IUB Commission on Biochemical Nomenclature (CBN). (1992) Numbering of atoms in myo-inositol, in Biochemical Nomenclature and Related Documents, 2nd edn, pp. 156157. Portland Press, London.
  • Ives E. B., Nichols J., Wente S. R. and York J. D. (2000) Biochemical and functional characterization of inositol 1,3,4,5,6-pentakisphosphate 2-kinases. J. Biol. Chem. 275, 3657536583.
  • Jackson P. S. and Madsen J. R. (1997) Identification of the volume-sensitive organic osmolyte/anion channel in human glial cells. Pediatr. Neurosurg. 27, 286291.
  • Jackson P. S. and Strange K. (1993) Volume-sensitive anion channels mediate swelling-activated inositol and taurine efflux. Am. J. Physiol. 265, C1489C1500.
  • Jackson P. S., Morrison R. and Strange K. (1994) The volume-sensitive organic osmolyte-anion channel VSOAC is regulated by nonhydrolytic ATP binding. Am. J. Physiol. 267, C1203C1209.
  • Jariwalla R. J. (1999) Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent. Anticancer Res. 19, 36993702.
  • Jenkinson S., Nahorski S. R. and Challiss R. A. (1994) Disruption by lithium of phosphatidylinositol-4,5-bisphosphate supply and inositol-1,4,5-trisphosphate generation in Chinese hamster ovary cells expressing human recombinant m1 muscarinic receptors. Mol. Pharmacol. 46, 11381148.
  • Johnson K., Barrientos L.G.Le L. and Murthy P.P. (1995) Application of two-dimensional total correlation spectroscopy for structure determination of individual inositol phosphates in a mixture. Anal. Biochem. 231, 421431.DOI: 10.1006/abio.1995.0073
  • Karihaloo A., Kato K., Greene D. A. and Thomas T. P. (1997) Protein kinase and Ca2+ modulation of myo-inositol transport in culturedretinal pigment epithelial cells. Am. J. Physiol. 273, C671C678.
  • Kennedy E. D., Challiss R. A. and Nahorski S. R. (1989) Lithium reduces the accumulation of inositol polyphosphate second messengers following cholinergic stimulation of cerebral cortex slices. J. Neurochem. 53, 16521655.
  • Kennedy E. D., Challiss R. A., Ragan C. I. and Nahorski S. R. (1990) Reduced inositol polyphosphate accumulation and inositol supply induced by lithium in stimulated cerebral cortex slices. Biochem. J. 67, 781786.
  • Klein P. S. and Melton D. A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl Acad. Sci. USA 93, 84558459.
  • Koch S., Chen G., Santalucia J. Jr, Manji H. K. and Moore G. J. (1999) Abundant levels of myo-inositol in cells of human neuronal origin. Abstracts Soc. Neurosci. 25, p. 2207.
  • Kouzuma T., Takahashi M., Endoh T., Kaneko R., Ura N., Shimamoto K. and Watanabe N. (2001) An enzymatic cycling method for the measurement of myo-inositol in biological samples. Clin. Chim. Acta 312, 143151.
  • Kwon H. M., Yamauchi A., Uchida S., Preston A. S., Garcia-Perez A., Burg M. B. and Handler J. S. (1992) Cloning of the cDNA for a Na+/myo-inositol cotransporter, a hypertonicity stress protein. J.Biol. Chem. 267, 62976301.
  • Lang F., Busch G. L., Ritter M., Völkl H., Waldegger S., Gulbins E. and Häussinger D. (1998) Functional significance of cell Volume regulatory mechanisms. Physiol. Rev. 78, 247306.
  • Lee C. H., Dixon J. F., Reichman M., Moummi C., Los G. and Hokin L.E. (1992) Li+ increases accumulation of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate in cholinergically stimulated brain cortex slices in guinea pig, mouse and rat. The increases require inositol supplementation in mouse and rat but not in guinea pig. Biochem. J. 282, 377385.
  • Lee J. H., Arcinue E. and Ross B. D. (1994) Brief report: organic osmolytes in the brain of an infant with hypernatremia. N. Engl. J. Med. 331, 439442.
  • Lemtiri-Chlieh F., MacRobbie E. A. and Brearley C. A. (2000) Inositol hexakisphosphate is a physiological signal regulating the K+-inward rectifying conductance in guard cells. Proc. Natl Acad. Sci. USA 97, 86878692.
  • Levine J. (1997) Controlled trials of inositol in psychiatry. Eur. Neuropsychopharmacol. 7, 147155.
  • Levine J., Gonzalves M., Barbam I., Stier S., Elizur A.,Kofman O., and Belmaker R.H. (1993) Inositol 6 gm daily may be effective in depression but not in schizophrenia. Hum. Psychopharmacol. 8, 4953.
  • Levine J., Barak Y., Gonzalves M., Elizur A., Schor H., Kofman O. and Belmaker R. H. (1995) Double blind study of inositol versus placebo in depression. Am. J. Psychiatry 152, 792794.
  • Levine J., Aviram A., Holan A., Ring A., Barak Y. and Belmaker R. H. (1997) Inositol treatment of autism. J. Neural Transm. 104, 307310.
  • Lien Y.-H. H., Shapiro J. I. and Chan L. (1990) Effects of hypernatremia on organic brain osmoles. J. Clin. Invest. 85, 14271435.
  • Llinas R., Sugimori M., Lang E. J., Morita M., Fukuda M., Niinobe M. and Mikoshiba K. (1994) The inositol high-polyphosphate series blocks synaptic transmission by preventing vesicular fusion: a squid giant synapse study. Proc. Natl Acad. Sci. USA 91, 1299012993.
  • Lohr J. W., McReynolds J., Grimaldi T. and Acara M. (1988) Effect of acute and chronic hypernatremia on myoinositol and sorbitol concentration in rat brain and kidney. Life Sci. 43, 271276.
  • Long C. (1961) Biochemists' Handbook p. 640. D. Van Nostrand Company, Inc, Princeton, New Jersey.
  • Low M. G. (2000) Glycosylphosphatidylinositol-anchored proteins and their phospholipases, in Biology of Phosphoinositides (CockcroftS., ed.), pp. 210239. Oxford University Press, Oxford.
  • Lubrich B., Spleiss O., Gebicke-Haerter P. J. and Van Calker D. (2000) Differential expression, activity and regulation of the sodium/myo-inositol cotransporter in astrocyte cultures from different regions of the rat brain. Neuropharmacology. 39, 680690.DOI: 10.1016/S0028-3908(99)00162-8
  • MacGregor L. C. and Matschinsky F. M. (1984) An enzymatic fluorimetric assay for myo-inositol. Anal. Biochem. 141, 382389.
  • Maeda T. and Eisenberg F. Jr (1980) Purification, structure, and catalytic properties of 1-myo-inositol-1-phosphate synthase from rat testis. J.Biol. Chem. 255, 84588464.
  • Maehama T. and Dixon J. E. (1998) The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 1337513378.
  • Martin J. B., Laussmann T., Bakker-Grunwald T., Vogel G. and Klein G. (2000) neo-Inositol polyphosphates in the amoeba Entamoeba histolytica. J. Biol. Chem. 275, 1013410140.
  • Matskevitch J., Wagner C. A., Risler T., Kwon H. M., Handler J. S., Waldegger S., Busch A. E. and Lang F. (1998) Effect of extracellular pH on the myo-inositol transporter SMIT expressed in Xenopus oocytes. Pflügers Arch. 436, 854857.
  • Mayr G. W. (1990) Mass determination of inositol phosphates by high-performance liquid chromatography with postcolumn complexometry (metal-dye detection), in Methods in Inositide Research (IrvineR. F., ed.), pp. 83108. Raven Press, New York.
  • McLaurin J., Golomb R., Jurewicz A., Antel J. P. and Fraser P. E. (2000) Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid β peptide and inhibit Aβ-induced toxicity. J. Biol. Chem. 275, 1849518502.
  • Menniti F. S., Miller R. N., Putney J. W. Jr and Shears S. B. (1993) Turnover of inositol polyphosphate pyrophosphates in pancreatoma cells. J. Biol. Chem. 268, 38503856.
  • Moore C. M., Breeze J. L., Kukes T. J., Rose S. L., Dager S. R., Cohen B. M. and Renshaw P. F. (1999) Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study. Biol. Psychiatry 45, 11971202.
  • Nonaka M., Yoshimine T., Kohmura E., Wakayama A., Yamashita T. and Hayakawa T. (1998) Changes in brain organic osmolytes in experimental cerebral ischemia. J. Neurol. Sci. 157, 2530.
  • Nonaka M., Kohmura E., Yamashita T., Yamauchi A., Fujinaka T., Yoshimine T., Tohyama M. and Hayakawa T. (1999) Kainic acid-induced seizure upregulates Na+/myo-inositol cotransporter mRNA in rat brain. Mol. Brain Res. 70, 179186.
  • Novak J. E., Turner R. S., Agranoff B. W. and Fisher S. K. (1999) Differentiated human NT2-N neurons possess a high intracellular content of myo-inositol. J. Neurochem. 72, 14311440.
  • Novak J. E., Agranoff B. W. and Fisher S. K. (2000) Regulation of myo-inositol homeostasis in differentiated human NT2-N neurons. Neurochem. Res. 25, 561566.
  • Ohara-Imaizumi M., Fukuda M., Niinobe M., Misonou H., Ikeda K., Murakami T., Kawasaki M., Mikoshiba K. and Kumakura K. (1997) Distinct roles of C2A and C2B domains of synaptotagmin in the regulation of exocytosis in adrenal chromaffin cells. Proc. Natl Acad. Sci. USA 94, 287291.
  • Pak Y., Huang L. C., Lilley K. J. and Larner J. (1992) In vivo conversion of [3H]myoinositol to [3H]chiroinositol in rat tissues. J. Biol. Chem. 267, 1690416910.
  • Palmano K. P., Whiting P. H. and Hawthorne J. N. (1977) Free and lipid myo-inositol in tissues from rats with acute and less severe streptozotocin-induced diabetes. Biochem. J. 167, 229235.
  • Paredes A., McManus M., Kwon H. M. and Strange K. (1992) Osmoregulation of Na+-inositol cotransporter activity and mRNA levels in brain glial cells. Am. J. Physiol. 263, C1282C1288.
  • Patishi Y., Lubrich B., Berger M., Kofman O., Van Calker D. and Belmaker R. H. (1996) Differential uptake of myo-inositol in vivo into rat brain areas. Eur. Neuropsychopharmacol. 6, 7375.
  • Porcellati F., Hlaing T., Togawa M., Stevens M. J., Larkin D. D., Hosaka Y., Glover T. W., Henry D. N., Greene D. A. and Killen P. D. (1998) Human Na+-myo-inositol cotransporter gene: alternate splicing generates diverse transcripts. Am. J. Physiol. 274, C1215C1225.
  • Posternak T. (1965) The Cyclitols., pp. 127144. Hermann, Paris.
  • Reboulleau C. P. (1990) Inositol metabolism during neuroblastoma B50 cell differentiation: effects of differentiating agents on inositol uptake. J. Neurochem. 55, 641650.
  • Rim J. S., Atta M. G., Dahl S. C., Berry G. T., Handler J. S. and Kwon H. M. (1998) Transcription of the sodium/myo-inositol cotransporter gene is regulated by multiple tonicity-responsive enhancers spread over 50 kilobase pairs in the 5′-flanking region. J. Biol. Chem. 273, 2061520621.
  • Ruhfus B. and Kinne R. K. H. (1996) Hypotonicity-activated efflux of taurine and myo-inositol in rat inner medullary collecting duct cells: evidence for a major common pathway. Kidney Blood Press Res. 19, 317324.
  • Ruhfus B., Tinel H. and Kinne R. K. H. (1996) Role of G-proteins in the regulation of organic osmolyte efflux from isolated rat renal inner medullary collecting duct cells. Pflügers Arch. 433, 3541.
  • Safrany S. T. and Shears S. B. (1998) Turnover of bis-diphosphoinositol tetrakisphosphate in a smooth muscle cell line is regulated by β2-adrenergic receptors through a cAMP-mediated, A-kinase-independent mechanism. EMBO J. 17, 17101716.
  • Safrany S. T., Caffrey J. J., Yang X., Bembenek M. E., Moyer M. B., Burkhart W. A. and Shears S. B. (1998) A novel context for the ‘MutT’ module, a guardian of cell integrity, in a diphosphoinositol polyphosphate phosphohydrolase. EMBO J. 17, 65996607.
  • Safrany S. T., Caffrey J. J., Yang X. and Shears S. B. (1999) Diphosphoinositol polyphosphates: the final frontier for inositide research? Biol. Chem. 380, 945951.
  • Saiardi A., Caffrey J. J., Snyder S. H. and Shears S. B. (2000) The inositol hexakisphosphate kinase family. Catalytic flexibility and function in yeast vacuole biogenesis. J. Biol. Chem. 275, 2468624692.
  • Saiardi A., Nagata E., Luo H. R., Sawa A., Luo X., Snowman A. M. and Snyder S. H. (2001a) Mammalian inositol polyphosphate multikinase synthesizes inositol 1,4,5-trisphosphate and an inositol pyrophosphate. Proc. Natl Acad. Sci. USA 98, 23062311.
  • Saiardi A., Nagata E., Luo H. R., Snowman A. M. and Snyder S. H. (2001b) Identification and characterization of a novel inositol hexakisphosphate kinase. J. Biol. Chem. 276, 3917939185.
  • Sasakawa N., Sharif M. and Hanley M. R. (1995) Metabolism and biological activities of inositol pentakisphosphate and inositol hexakisphosphate. Biochem. Pharmacol. 50, 137146.
  • Scherer J. (1850) Ueber eine neue, aus dem Muskelfleische gewonnene Zuckerart. Liebigs Ann. Chem. 73, 322328.
  • Scholz P., Bergmann G. and Mayr G. W. (1990) Nuclear magnetic resonance spectroscoy of myo-inositol phosphates, in Methods in Inositide Research (IrvineR. F., ed.), pp. 6582. Raven Press, New York.
  • Seaquist E. R. and Gruetter R. (1998) Identification of a high concentration of scyllo-inositol in the brain of a healthy human subject using 1H- and 13C-NMR. Magn. Reson. Med. 39, 313316.
  • Seiffert U. B. and Agranoff B. W. (1965) Isolation and separation of inositol phosphates from hydrolysates of rat tissues. Biochim. Biophys. Acta. 98, 574581.
  • Shears S. B. (2001) Assessing the omnipotence of inositol hexakisphosphate. Cell Signal 13, 151158.
  • Shears S. B., Ali N., Craxton A. and Bembenek M. E. (1995) Synthesis and metabolism of bis-diphosphoinositol tetrakisphosphate in vitro and in vivo. J. Biol. Chem. 270, 1048910497.
  • Sherman W. R., Stewart M. A., Kurien M. M. and Goodwin S. L. (1968a) The measurement of myo-inositol, myo-inosose-2 and scyllo-inositol in mammalian tissues. Biochim. Biophys. Acta 158, 197205.
  • Sherman W. R., Stewart M. A., Simpson P. C. and Goodwin S. L. (1968b) The identification of myo-inosose-2 and scyllo-inositol in mammalian tissues. Biochemistry 7, 819824.
  • Sherman W. R., Goodwin S. L. and Gunnell K. D. (1971) neo-Inositol in mammalian tissues. Identification, measurement, and enzymatic synthesis from mannose 6-phosphate. Biochemistry 10, 34913499.
  • Sherman W. R., Packman P. M., Laird M. H. and Boshans R. L. (1977) Measurement of myo-inositol in single cells and defined areas of the nervous system by selected ion monitoring. Anal. Biochem. 78, 119131.
  • Sherman W. R., Gish B. G., Honchar M. P. and Munsell L. Y. (1986) Effects of lithium on phosphoinositide metabolism in vivo. Fed. Proc. 45 , 26392646.
  • Shetty H. U., Holloway H. W. and Rapoport S. I. (1995a) Capillary gas chromatography combined with ion trap detection for quantitative profiling of polyols in cerebrospinal fluid and plasma. Anal. Biochem. 224, 279285.DOI: 10.1006/abio.1995.1041
  • Shetty H. U., Schapiro M. G., Holloway H. W. and Rapoport S. I. (1995b) Polyol profiles in Down syndrome. myo× Inositol, specifically, is elevated in the cerebrospinal fluid. J. Clin. Invest. 95, 542546.
  • Shetty H. U., Siarey R. J., Galdzicki Z., Stoll J. and Rapoport S. I. (2000) Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues. Neurochem. Res. 25, 431435.
  • Shimon H., Sobolev Y., Davidson M., Haroutunian V., Belmaker R. H. and Agam G. (1998) Inositol levels are decreased in postmortem brain of schizophrenic patients. Biol. Psychiatry 44, 428432.
  • Shonk T. and Ross B. D. (1995) Role of increased cerebral myo-inositol in the dementia of Down syndrome. Magn. Reson. Med. 33, 858861.
  • Sigal S. H., Yandrasitz J. R. and Berry G. T. (1993) Kinetic evidence for compartmentalization of myo-inositol in hepatocytes. Metabolism 42, 395401.
  • Sloane-Stanley G. H. (1953) Anaerobic reactions of phospholipins in brain suspensions. Biochem. J. 53, 613619.
  • Song D., O'Regan M. H. and Phillis J. W. (1998) Protein kinase inhibitors attenuate cardiac swelling-induced amino acid release in the rat. J. Pharm. Pharmacol. 50, 12801286.
  • Spector R. (1978) The transport and metabolism of scyllo-inositol in the central nervous system. J. Neurochem. 31, 11131115.
  • Stephens L., Radenberg T., Thiel U., Vogel G., Khoo K.H.,Dell A.Jackson T.R.Hawkins P.T. and Mayr G.W. (1993) The detection, purification, structural characterization, and metabolism ofdiphosphoinositol pentakisphosphate (s) and bisdiphosphoinositol tetrakisphosphate (s). J. Biol. Chem. 268, 40094015.
  • Stokes C. E. and Hawthorne J. N. (1987) Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. J. Neurochem. 48, 10181021.
  • Stokes C. E., Gillon K. R. and Hawthorne J. N. (1983) Free and total lipid myo-inositol concentrations decrease with age in human brain. Biochim. Biophys. Acta. 753, 136138.
  • Strange K. (1992) Regulation of solute and water balance and cell Volume in the central nervous system. J. Am. Soc. Nephrol. 3, 1227.
  • Strange K., Morrison R., Heilig C. W., DiPietro S. and Gullans S. R. (1991) Upregulation of inositol transport mediates inositol accumulation in hyperosmolar brain cells. Am. J. Physiol. 260, C784C790.
  • Strange K., Morrison R., Shrode L. and Putnam R. (1993) Mechanism and regulation of swelling-activated inositol efflux in brain glial cells. Am. J. Physiol. 265, C244C256.
  • Strange K., Emma F., Paredes A. and Morrison R. S. (1994) Osmoregulatory changes in myo-inositol content and Na+/myo-inositol cotransport in rat cortical astrocytes. Glia 12, 3543.
  • Stubbs E. B. and Agranoff B. W. (1993) Lithium enhances muscarinic receptor-stimulated CDP-diacylglycerol formation in inositol-depleted SK-N-SH neuroblastoma cells. J. Neurochem. 60, 12921299.
  • Sun M. K., Wahlestedt C. and Reis D. J. (1992) Inositol hexakisphosphate excites rat medullary sympathoexcitatory neurons in vivo. Eur. J. Pharmacol. 215, 916.
  • Sundkvist G., Dahlin L. B., Nilsson H., Eriksson K. F., Lindgarde F., Rosen I., Lattimer S. A., Sima A. A., Sullivan K. and Greene D. A. (2000) Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance. Diabet. Med. 17, 259268.DOI: 10.1046/j.1464-5491.2000.00261.x
  • Thurston J. H., Sherman W. R., Hauhart R. E. and Kloepper R. F. (1989) myo-inositol: a newly identified nonnitrogenous osmoregulatory molecule in mammalian brain. Pediatr. Res. 26, 482485.
  • Toker A. and Cantley L. C. (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387, 673676.
  • Uldry M., Ibberson M., Horisberger J. D., Chatton J. Y., Riederer B. M. and Thorens B. (2001) Identification of a mammalian H (+)-myo-inositol symporter expressed predominantly in the brain. EMBO J. 20, 44674477.
  • Vallejo M., Jackson T., Lightman S. and Hanley M.R. (1987) Occurrence and extracellular actions of inositol pentakis- and hexakisphosphate in mammalian brain. Nature 330, 656658.
  • Vanhaesebroeck B., Leevers S. J., Ahmadi K., Timms J., Katso R., Driscoll P. C., Woscholski R., Parker P. J. and Waterfield M. D. (2001) Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 70, 535602.
  • Venkatachalam M. A. and Buja M. (1994) Cellular injury and cellular death, in Robbins Pathologic Basis of Disease, 5th edn. (CotranR.S., KumarV., RobbinsS. L. and SchoenF. J., eds), pp. 134. W.B. Saunders Company, Philadelphia.
  • Videen J. S., Michaelis T., Pinto P. and Ross B. D. (1995) Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study. J. Clin. Invest. 95, 788793.
  • Voglmaier S. M., Keen J. H., Murphy J. E., Ferris C. D., Prestwich G.D., Snyder S. H. and Theibert A. B. (1992) Inositol hexakisphosphate receptor identified as the clathrin assembly protein AP-2. Biochem. Biophys. Res. Commun. 187, 158163.
  • Voglmaier S. M., Bembenek M. E., Kaplin A. I., Dorman G., Olszewski J. D., Prestwich G. D. and Snyder S. H. (1996) Purified inositol hexakisphosphate kinase is an ATP synthase: diphosphoinositol pentakisphosphate as a high-energy phosphate donor. Proc. Natl Acad. Sci. USA 93, 43054310.
  • Wiese T. J., Dunlap J. A., Conner C. E., Grzybowski J. A., Lowe W. L. and Yorek M. A. (1996) Osmotic regulation of Na-myo-inositol cotransporter mRNA level and activity in endothelial and neural cells. Am. J. Physiol. 270, C990C997.
  • Wiesinger H. (1991) myo-inositol transport in mouse astroglia-rich primary cultures. J. Neurochem. 56, 16981704.
  • Wolfson M., Bersudsky Y., Hertz E., Berkin V., Zinger E. and Hertz L. (2000) A model of inositol compartmentation in astrocytes based upon efflux kinetics and slow inositol depletion after uptake inhibition. Neurochem. Res. 5, 977982.
  • Wong Y. H., Kalmbach S. J., Hartman B. K. and Sherman W. R. (1987) Immunohistochemical staining and enzyme activity measurements show myo-inositol-1-phosphate synthase to be localized in the vasculature of brain. J. Neurochem. 48, 14341442.
  • Yamaguchi Y., Ikenaka K., Niinobe M., Yamada H. and Mikoshiba K. (1996) Myelin proteolipid protein (PLP), but not DM-20, is an inositol hexakisphosphate-binding protein. J. Biol. Chem. 271, 2783827846.
  • Yamashita T., Shimada S., Yamauchi A., Guo W., Kohmura E., Hayakawa T. and Tohyama M. (1997) Induction of Na+/myo-inositol co-transporter mRNA after rat cryogenic injury. Brain Res. Mol. Brain Res. 46, 236242.
  • Yang S. N. Yu J., Mayr G. W., Hofmann F., Larsson O. and Berggren P.O. (2001) Inositol hexakisphosphate increases 1-type Ca2+ channel activity by stimulation of adenylyl cyclase. FASEB J. 15, 17531763.
  • Ye W., Ali N., Bembenek M. E., Shears S. B. and Lafer E. M. (1995) Inhibition of clathrin assembly by high affinity binding of specific inositol polyphosphates to the synapse-specific clathrin assembly protein. J. Biol. Chem. 270, 15641568.
  • Yorek M. A., Dunlap J. A. and Ginsberg B. H. (1986) Myoinositol uptake by four cultured mammalian cell lines. Arch. Biochem. Biophys. 246, 801807.
  • Yorek M. A., Wiese T. J., Davidson E. P., Dunlap J. A., Stefani M. R., Conner C. E., Lattimer S. A., Kamijo M., Greene D. A. and Sima A. A. (1993) Reduced motor nerve conduction velocity and Na (+)-K (+)-ATPase activity in rats maintained on 1-fucose diet. Reversal by myo-inositol supplementation. Diabetes 42, 14011406.
  • Yorek M. A., Dunlap J. A., Manzo-Fontes A., Bianchi R., Berry G. T. and Eichberg J. (1999) Abnormal myo-inositol and phospholipid metabolism in cultured fibroblasts from patients with ataxia telangiectasia. Biochim. Biophys. Acta. 1437, 287300.
  • York J. D., Odom A. R., Murphy R., Ives E. B. and Wente S. R. (1999) A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. Science 285, 96100.
  • Young L. (1934) The determination of inositol in animal tissues. Biochem. J. 34, 14351443.